Action:
Definition of covered substances
Action 5088
General Information
Action Summary |
On July 1, 2018, the Code was changed to include the following in the covered substances that must be reported to the Prescription Monitoring Program: 1) Schedule V drugs for which a prescription is required; 2) the drug naloxone; and 3) cannabidiol oil or THC-A oil dispensed by a pharmaceutical processor in Virginia. |
Chapters Affected |
Only affects this chapter.
|
Executive Branch Review |
This Action is exempt from Article 2 of the Administrative Process Act.
The normal executive branch review process is not required. As such, it can be submitted directly for publication and
is effective upon publication.
Exempt Citation:
2.2-4006
|
RIS Project |
Yes [005571] |
Associated Mandates |
Addition of covered substances to Prescription Monitoring Program
|
New Periodic Review |
This action will not be used to conduct a new periodic review.
|
Stages
Stages associated with this regulatory action.
Stage ID |
Stage Type |
Status |
8337
|
Final
|
Stage complete. This regulation became effective on 10/03/2018. |
Contact Information
Name / Title:
|
Ashley Carter
/
Program Manager
|
Address:
|
9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
|
Email Address:
|
ashley.carter@dhp.virginia.gov
|
Phone:
|
(804)597-4282
FAX: ()-
TDD: ()-
|
This person is the primary contact for this chapter.